AU2001267887A1 - Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components - Google Patents

Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components

Info

Publication number: AU2001267887A1
Authority: AU; Australia
Prior art keywords: components; medicinal; parathyroid hormone; nasal administration; administration containing
Prior art date: 2000-06-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2001267887A

Other versions

AU2001267887B2 (en

Inventor

Kouji Kawanishi

Yoshiharu Minamitake

Tetsu Ono

Yuji Suzuki

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Asubio Pharma Co Ltd

Original Assignee

Asubio Pharma Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-30

Filing date

2001-06-29

Publication date

2002-04-11

2001-06-29 Application filed by Asubio Pharma Co Ltd filed Critical Asubio Pharma Co Ltd

2001-06-29 Priority claimed from PCT/JP2001/005674 external-priority patent/WO2002002136A1/en

2002-04-11 Publication of AU2001267887A1 publication Critical patent/AU2001267887A1/en

2003-11-27 Assigned to DAIICHI SUNTORY PHARMA CO LTD reassignment DAIICHI SUNTORY PHARMA CO LTD Request for Assignment Assignors: SUNTORY LIMITED

2004-01-08 Assigned to DAIICHI SUNTORY PHARMA CO., LTD. reassignment DAIICHI SUNTORY PHARMA CO., LTD. Amend patent request/document other than specification (104) Assignors: DAIICHI SUNTORY PHARMA CO LTD

2006-01-12 Assigned to DAIICHI ASUBIO PHARMA CO., LTD reassignment DAIICHI ASUBIO PHARMA CO., LTD Request for Assignment Assignors: DAIICHI SUNTORY PHARMA CO., LTD.

2007-02-15 Application granted granted Critical

2007-02-15 Publication of AU2001267887B2 publication Critical patent/AU2001267887B2/en

2007-05-24 Assigned to ASUBIO PHARMA CO., LTD reassignment ASUBIO PHARMA CO., LTD Request for Assignment Assignors: DAIICHI ASUBIO PHARMA CO., LTD

2007-08-30 Assigned to ASUBIO PHARMA CO., LTD. reassignment ASUBIO PHARMA CO., LTD. Request for Assignment Assignors: ASUBIO PHARMA CO., LTD

2021-06-29 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
JP2000237717		2000-06-30
JP2000-237718		2000-06-30
JP2000237718		2000-06-30
JP2000-237717		2000-06-30
PCT/JP2001/005674 WO2002002136A1 (en)	2000-06-30	2001-06-29	Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components

Publications (2)

Publication Number	Publication Date
AU2001267887A1 true AU2001267887A1 (en)	2002-04-11
AU2001267887B2 AU2001267887B2 (en)	2007-02-15

Family

ID=26597441

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU6788701A Pending AU6788701A (en)	2000-06-30	2001-06-29	Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components
AU2001267887A Ceased AU2001267887B2 (en)	2000-06-30	2001-06-29	Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU6788701A Pending AU6788701A (en)	2000-06-30	2001-06-29	Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components

Country Status (16)

Country	Link
US (1)	US7087248B2 (en)
EP (1)	EP1297842A4 (en)
KR (1)	KR20030016315A (en)
CN (1)	CN100518819C (en)
AR (1)	AR032461A1 (en)
AU (2)	AU6788701A (en)
BR (1)	BR0112381A (en)
CA (1)	CA2414966A1 (en)
IL (1)	IL153678A0 (en)
MX (1)	MXPA02012947A (en)
MY (1)	MY136546A (en)
NO (1)	NO325831B1 (en)
NZ (1)	NZ523457A (en)
RU (1)	RU2292219C2 (en)
TW (1)	TWI293563B (en)
WO (1)	WO2002002136A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2517310C (en) *	2003-02-28	2015-11-24	Chugai Seiyaku Kabushiki Kaisha	Stabilized protein-containing formulations comprising a poloxamer
CN101005851A (en) *	2004-07-14	2007-07-25	中外制药株式会社	PTH-containing preparation for transmucosal administration
BRPI0618469A2 (en) *	2005-11-10	2011-08-30	Univ Michigan Tech	black bear parathyroid hormone and methods of using black bear parathyroid hormone
EP1961765A1 (en) *	2006-12-08	2008-08-27	Zealand Pharma A/S	Truncated PTH peptides with a cyclic conformation
KR200449313Y1 (en) *	2008-02-18	2010-06-30	손복만	Pass-through with freeze drain valve
JP2011001317A (en) *	2009-06-19	2011-01-06	Fumakilla Ltd	Cleaning agent for nose
ES2662018T3 (en)	2009-09-09	2018-04-05	Asahi Kasei Pharma Corporation	Therapeutic / prophylactic agent containing PTH for osteoporosis, characterized in that PTH is administered once a week in a unit dose of 200 units
US20110172154A1 (en)	2009-11-18	2011-07-14	Asahi Kasei Pharma Corporation	Preventive and/or therapeutic and/or aggravation suppressing agent for human arthritis deformans
CA2782640A1 (en)	2009-12-07	2011-06-16	Michigan Technological University	Black bear parathyroid hormone and methods of using black bear parathyroid hormone
EP2471554A1 (en)	2010-12-28	2012-07-04	Hexal AG	Pharmaceutical formulation comprising a biopharmaceutical drug
KR20150116468A (en)	2011-06-07	2015-10-15	아사히 가세이 파마 가부시키가이샤	Freeze-dried preparation containing high-purity pth and method for producing same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4086196A (en) *	1975-03-28	1978-04-25	Armour Pharmaceutical Company	Parathyroid hormone
JP2505812B2 (en) *	1987-07-10	1996-06-12	旭化成工業株式会社	Freeze-dried composition of h-PTH (1-34)
GB9020544D0 (en)	1990-09-20	1990-10-31	Sandoz Ltd	Improvements in or relating to organic compounds
US5208041A (en)	1991-05-23	1993-05-04	Allelix Biopharmaceuticals Inc.	Essentially pure human parathyroid hormone
JPH05271279A (en) *	1991-08-07	1993-10-19	Takeda Chem Ind Ltd	Human parathyroid hormone mutein and its production
US5977070A (en) *	1992-07-14	1999-11-02	Piazza; Christin Teresa	Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
DE19538687A1 (en) *	1995-10-17	1997-04-24	Boehringer Mannheim Gmbh	Stable pharmaceutical dosage forms containing parathyroid hormone
ZA9811127B (en) *	1997-12-09	2000-07-11	Lilly Co Eli	Stabilized teriparatide solutions.

2001
- 2001-06-29 TW TW090116031A patent/TWI293563B/en not_active IP Right Cessation
- 2001-06-29 CA CA002414966A patent/CA2414966A1/en not_active Abandoned
- 2001-06-29 AU AU6788701A patent/AU6788701A/en active Pending
- 2001-06-29 CN CNB018120636A patent/CN100518819C/en not_active Expired - Fee Related
- 2001-06-29 MX MXPA02012947A patent/MXPA02012947A/en active IP Right Grant
- 2001-06-29 BR BR0112381-5A patent/BR0112381A/en not_active Application Discontinuation
- 2001-06-29 US US10/312,726 patent/US7087248B2/en not_active Expired - Fee Related
- 2001-06-29 NZ NZ523457A patent/NZ523457A/en not_active IP Right Cessation
- 2001-06-29 IL IL15367801A patent/IL153678A0/en unknown
- 2001-06-29 MY MYPI20013133A patent/MY136546A/en unknown
- 2001-06-29 KR KR1020027017881A patent/KR20030016315A/en not_active Ceased
- 2001-06-29 EP EP01945732A patent/EP1297842A4/en not_active Withdrawn
- 2001-06-29 WO PCT/JP2001/005674 patent/WO2002002136A1/en not_active Ceased
- 2001-06-29 AU AU2001267887A patent/AU2001267887B2/en not_active Ceased
- 2001-06-29 AR ARP010103122A patent/AR032461A1/en unknown
- 2001-06-29 RU RU2003102629/15A patent/RU2292219C2/en not_active IP Right Cessation
2002
- 2002-12-17 NO NO20026055A patent/NO325831B1/en not_active IP Right Cessation

Similar Documents

Publication	Publication Date	Title
SI1385494T1 (en)	2016-09-30	Compositions containing formoterol and a steroid for delivery into the lungs
HUP0101293A3 (en)	2001-12-28	Aspb28-human insulin comprising pharmaceutical composition administered by inhalation and their use
IL145983A0 (en)	2002-07-25	Pharmaceutical composition for dermal use, comprising a corticosteroid and a vitamin d or an analogue thereof
HUP0104574A3 (en)	2002-09-30	Analogues of glp-1, pharmaceutical compositions comprising thereof and their use
HUP0104579A3 (en)	2002-05-28	Glp-1 analogues, pharmaceutical compositions comprising thereof and their use
AU2001283563A1 (en)	2002-02-25	Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
SI1329456T1 (en)	2006-12-31	Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
IL152024A0 (en)	2003-04-10	Pharmaceutical compositions containing thyroid hormone and processes for the manufacture thereof
IL127572A (en)	2003-04-10	Pharmaceutical composition and medicament for nasal administration
HUP0202862A3 (en)	2003-10-28	Pharmaceutical composition containing novel combination of loteprednol and antihistamines
HUP0302311A3 (en)	2006-07-28	Medicinal aerosol formulations
ZA200308221B (en)	2004-09-29	Pharmaceutical compositions for oral and topical administration.
AU2001258550A1 (en)	2001-11-26	Insulin formulation for inhalation
AU2001267887A1 (en)	2002-04-11	Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components
HUP0400120A3 (en)	2012-09-28	Pharmaceutical composition for orally administering parathyroid hormone and calcitonin
AU6788701A (en)	2002-01-14	Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components
IL160886A0 (en)	2004-08-31	Nicotine containing pharmaceutical formulations and use thereof
AU5654701A (en)	2001-11-26	Drug delivery mask
AU2001274236A1 (en)	2001-12-24	Dry-powder pharmaceutical formulation for inhalation comprising alpha4-intergrinantagonist
GB0201607D0 (en)	2002-03-13	Formulation for the administration of medicinal substances
SI1406591T1 (en)	2007-06-30	Pharmaceutical composition for nasal delivery of estradiol and norethisterone
AU2002336141A1 (en)	2003-05-29	Pharmaceutical composition for nasal delivery of estradiol and norethisterone
AU2001287930A1 (en)	2002-04-02	Pharmaceutical formulation for pulmonary or nasal administration
AU2001284287A1 (en)	2002-03-22	Pharmaceutical combination containing salmeterol and fluticasone
AU6633101A (en)	2002-01-08	Peptide compound and pharmaceutical compositions and medicines containing the same as the active ingredient